Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nekkar | 0TT | Oct 16, 2024 | 0.73 | -1.87 |
Nektar Therapeutics | ITH | Oct 16, 2024 | 1.16 | -2.35 |
NEL | D7G | Oct 16, 2024 | 0.36 | -8.63 |
Nel ASA Unsponsored ADR (Norway) | D7GA | Oct 16, 2024 | 9.75 | -2.50 |
Nelly Group | CD20 | Oct 16, 2024 | 2.17 | +0.23 |
Nelnet, Inc. | NIJ | Oct 16, 2024 | 103.00 | 0.00 |
NEMETSCHEK UNSP.ADR/0,2 | NEM0 | Oct 16, 2024 | 18.90 | -1.56 |
Nemetschek SE | NEM | Oct 16, 2024 | 101.50 | +0.50 |
NENT Group B | NEB | Oct 16, 2024 | 0.06 | -0.66 |
Neo Performance Materials Inc | N14 | Oct 16, 2024 | 5.10 | -1.35 |
NEO-NEON | N2L | Oct 16, 2024 | 0.04 | +0.28 |
Neodecortech S.p.a. | FM2 | Oct 16, 2024 | 2.95 | -1.67 |
Neoen S.A. | N1N | Oct 16, 2024 | 39.02 | +0.15 |
NEOENERGIA UNSP.ADR 1 | 2Q40 | Oct 16, 2024 | 11.20 | 0.00 |
Neogen Corporation | NG2 | Oct 16, 2024 | 13.30 | +4.72 |
NeoGenomics, Inc. | NG9 | Oct 16, 2024 | 12.80 | +1.59 |
Neolife | 8JB | Oct 16, 2024 | 0.05 | -8.79 |
Neometals Ltd | 9R9 | Oct 16, 2024 | 0.06 | -10.32 |
NEOMETALS LTD SP.ADS/10 | 9R91 | Oct 16, 2024 | 0.47 | -10.00 |
NEON EQUITY NA O.N. | D77 | Oct 16, 2024 | 1.76 | 0.00 |
NeonMind Biosciences Inc | 6UF0 | Oct 16, 2024 | 0.01 | +120.00 |
Neosperience S.p.a | Y8E | Oct 16, 2024 | 0.76 | -1.30 |
NEOTECH METALS CORP. | V690 | Oct 16, 2024 | 0.09 | +15.38 |
Nephros | NPJP | Oct 16, 2024 | 1.45 | +6.62 |
Neptune Digital Assets Corp. | 1NW | Oct 16, 2024 | 0.19 | -2.31 |
Nerds On Site Inc | 3NS | Oct 16, 2024 | 0.02 | -12.00 |
Nerdwallet Inc | 6OI | Oct 16, 2024 | 11.40 | +1.79 |
NervGen Pharma Corp | 9UA | Oct 16, 2024 | 1.54 | +6.21 |
Neste | NEF | Oct 16, 2024 | 16.19 | -0.25 |
Neste OYJ American Depositary Receipts - Unsponsored | NEFA | Oct 16, 2024 | 7.80 | -5.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.